Abstract
The incidence of cardiovascular and kidney disease with age is growing steadily worldwide. The factors for cardiovascular and kidney diseases are similar at elderly ages. Left ventricular hypertrophy (LVH) in chronic kidney disease (CKD) at an elderly age is not well understood. The goal of this study was to examine changes in a structural state of the left ventricular myocardium depending on the severity of clinical and laboratory manifestations of CKD in elderly patients. Clinical, laboratory, and instrumental examination of 62 patients at ages of 60 to 74 years (the young old) was carried out; the average age was 63.7 ± 3.66 years. The study involved the analysis of parameters of red blood, lipid spectrum, creatinine, daily proteinuria, C-reactive protein, and blood electrolytes. Glomerular filtration rate (GFR) was assessed using the CKD-EPI formula. The eccentric type was found to be the predominant variant of LVH at the early stages of CKD (S1, S2, and S3) at elderly ages. In the presence of renal failure (S4 and S5 of CKD), changes in the structure of the myocardium are characterized by a predominantly concentric type of left ventricular remodeling in the elderly. The factors associated with the development of left ventricular remodeling in elderly patients with CKD included age, arterial hypertension, anemia, dyslipidemia, and proteinuria, as well as an appreciable decline in the level of GFR.
Similar content being viewed by others
REFERENCES
Alekseev, I.A., Comparative analysis of the severity of left ventricular hypertrophy and contractile function of the myocardium in elderly and senile patients with arterial hypertension, Sib. Med. Obozr., 2017, no. 2, pp. 66–71. https://doi.org/10.20333/2500136-2017-2-66-71
Anisimov, V.N., Aging and age-related diseases, Klin. Gerontol., 2005, vol. 11, no. 1, pp. 42–49.
Anisimov, V.N., Bordovskii, G.A., Finagentov, A.V., et al., Governmental support of older citizens: what kind of geriatrics does modern Russia need, Usp. Gerontol., 2020, vol. 33, no. 4, pp. 625–645. https://doi.org/10.34922/AE.2020.33.4.002
Anisimov, V.N., Red’ko, A.A., Finagentov, A.V., et al., System support for improving the quality of life of older citizens in Russia: problems and prospects, Usp. Gerontol., 2020, vol. 33, no. 5, pp. 825–837. https://doi.org/10.34922/AE.2020.33.5.002
Annan, K., UN Secretary-General, Opening Second World Assembly on Ageing in Madrid, Urges Plan of Action to build a Society for all ages, Madrid, 2002. http://www.un.org/ru/documents/decl_conv/declarations/ageing_program.shtml. Cited July 27, 2021.
Barbarash, V.L., Kashtalap, V.V., and Krivoshapova, K.E., Elderly patient with ischemic heart disease, Med. Alfavit, 2021, no. 1, vol. 11, pp. 8–11. https://doi.org/10.33667/2078-5631-2021-11-8-11
Lapteva, E.S., Ariev, A.L., Tsutsunava, M.R., and Arieva, G.T., Comprehensive geriatric assessment—resolved and unresolved issues (review), Adv. Gerontol., 2021, vol. 11, no. 4, pp. 333–340. https://doi.org/10.1134/S207905702104007X
Levitskaya, E.S., Batyushin, M.M., Bondarenko, O.K., et al., Prediction of the development of fibrosis of the small arterial channel in patients with arterial hypertension and primary chronic glomerulonephritis, Kardiovaskulyarnaya, Ter. Profil., 2020, vol. 19, no. 3, p. 2491. https://doi.org/10.15829/1728-8800-2020-2491
Murkamilov, I.T., Sabirov, I.S., Aitbaev, K.A., et al., Renal dysfunction and indicators of arterial stiffness in elderly and senile patients, Usp. Gerontol., 2018, vol. 31, no. 4, pp. 549–555.
Murkamilov, I.T., Aitbaev, K.A., Fomin, V.V., et al., Clinical and functional features of arterial stiffness in the elderly people, Sist. Gipertenzii, 2021, vol. 18, no. 1, pp. 31–36. https://doi.org/10.26442/2075082X.2021.1.200721
Ostroumova, O.D., Alyautdinova, I.A., Butorov, V.N., et al., Optimization of pharmacotherapy in a polymorbid patient with a combination of chronic heart failure and chronic kidney disease: a clinical case, Consilium Med., 2020, vol. 22, no. 1, pp. 38–43.
Paketov, S.A., Oskolkov, S.A., Zhmurov, V.A., et al., Central hemodynamic parameters according to echocardiography in patients with chronic kidney disease on the background of chronic pyelonephritis, Med. Nauka Obarz. Urala, 2020, vol. 21, no. 3, pp. 73–75. https://doi.org/10.36361/1814-8999-2020-21-3-73-75
Rubinskii, A.V., Lin’kova, N.S., Chalisova, N.I., et al., Epigenetic regulation of adaptogenesis in pathology and aging, Usp. Gerontol., 2021, vol. 34, no. 1, pp. 10–17. https://doi.org/10.34922/AE.2021.34.1.001
Smirnov, A.V., Dobronravov, V.A., Kayukov, I.G., et al., Epidemiology and socioeconomic aspects of chronic kidney disease, Nefrologiya, 2006, vol. 10, no. 1, pp. 7–13. https://doi.org/10.24884/1561-6274-2006-10-1-7-13
Storozhakov, G.I., Chervyakova, Yu.B., Vereshchagin, G.S., et al., Elastic properties of the arterial wall in elderly patients with arterial hypertension, Klin. Gerontol., 2006, vol. 10, pp. 33–38.
Khurs, E.M., Poddubnaya, A.V., and Evsina, M.G., Influence of dyslipidemia on early structural-geometric reorganization of the heart in patients with arterial hypertension, Arterial’naya Gipertenziya, 2010, vol. 16, no. 5, pp. 511–516. https://doi.org/10.18705/1607-419X-2010-5-
Chazova, I.E. and Zhernakova, Yu.V., Expert opinion. Clinical guidelines: diagnostics and treatment of arterial hypertension, Sist. Gipertenzii, 2019, vol. 16, no. 1, pp. 6–31. https://doi.org/10.26442/2075082X.2019.1.190179
Chernyavina, A.I. and Koziolova, N.A., The relationship of left ventricular hypertrophy with impaired filtration and tubulointerstitial functions of the kidneys in patients with hypertension, Neotlozhnaya Kardiol. Kardiovaskulyarnye Riski, 2020, vol. 4, no. 1, pp. 861–866. http://rep.bsmu.by:8080/handle/BSMU/29006
Atkins, R.C., The epidemiology of chronic kidney disease, Kidney Int. Suppl., 2005, vol. 94, pp. S14–S18. https://doi.org/10.1111/j.1523-1755.2005.09403.x
Gluba-Brzózka, A., Franczyk, B., Olszewski, R., et al., The influence of inflammation on anemia in CKD patients, Int. J. Mol. Sci., 2020, vol. 21, no. 3, p. 725. https://doi.org/10.3390/ijms21030725
Harper, C.R. and Jacobson, T.A., Managing dyslipidemia in chronic kidney disease, J. Am. College Cardiol., 2008, vol. 51, no. 25, pp. 2375–2384.
Iseki, K., Iseki, C., Ikemiya, Y., and Fukiyama, K., Risk of developing end-stage renal disease in a cohort of mass screening, Kidney Int., 1996, vol. 49, no. 3, pp. 800–805. https://doi.org/10.1038/ki.1996.111
Kalu, O.K., Hart, O.C., Ifeoma, C.N., et al., Patterns and predictors of left ventricular hypertrophy in Nigerians with chronic kidney disease, Ann. Clin. Cardiol., 2021, vol. 3, no. 1, pp. 33–38. https://doi.org/10.4103/ACCJ.ACCJ_41_20
Kim, I.Y., Ye, B.M., Kim, M. J., et al., Association between serum uric acid and left ventricular hypertrophy/left ventricular diastolic dysfunction in patients with chronic kidney disease, PLoS One, 2021, vol. 16, no. 5, p. e0251333. https://doi.org/10.1371/journal.pone.0251333
Lang, R.M., Badano, L.P., Mor-Avi, V., et al., Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging, Eur. Heart J. Cardiovasc. Imaging, 2015, vol. 16, no. 3, pp. 233–271.
Levey, A.S., Coresh, J., Bolton, K., et al., K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification, Am. J. Kidney Dis., 2002, vol. 39, suppl. 1, p. 2.
Lurbe, E., Agabiti-Rosei, E., Cruickshank, J.K., et al., 2016 European Society of Hypertension guidelines for the management of high blood pressure in children and adolescents, J. Hypertens., 2016, vol. 34, no. 10, pp. 1887–1920.
Majoni, S.W., Lawton, P.D., Rathnayake, G., et al., Narrative review of hyperferritinemia, iron deficiency, and the challenges of managing anemia in aboriginal and Torres Strait islander Australians with CKD, Kidney Int. Rep., 2021, vol. 6, no. 2, pp. 501–512. https://doi.org/10.1016/j.ekir.2020.10.035
McCullough, P.A., Anemia of cardiorenal syndrome, Kidney Int. Suppl., 2021, vol. 11, no. 1, pp. 35–45. https://doi.org/10.1016/j.kisu.2020.12.001
Podestà, M.A., Valli, F., Galassi, A., et al., The impact of old and novel cardiovascular risk factors, Blood Purif., 2021, vol. 50, pp. 740–749. https://doi.org/10.1159/000514467
Zicarelli, M.T., Patella, G., Bolignano, D., et al., Nephrosclerosis impacts time trajectory of renal function and outcomes in elderly individuals with chronic kidney disease, J. Invest. Med., 2021, vol. 69, pp. 1411–1416. https://doi.org/10.1136/jim-2021-001854
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interests. The authors declare that they have no conflict of interest.
Statement of compliance with standards of research involving humans as subjects. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all individual participants involved in the study. Informed consent was obtained from all individual participants involved in the study.
Additional information
Translated by E. Kuznetsova
Rights and permissions
About this article
Cite this article
Murkamilov, I.T., Sabirov, I.S., Fomin, V.V. et al. Interrelation of Changes in the Left Ventricular Myocardium and Evidence of Clinical and Laboratory Indicators in Chronic Kidney Disease of Elderly. Adv Gerontol 12, 72–78 (2022). https://doi.org/10.1134/S207905702201009X
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S207905702201009X